Login / Signup
Ryo Hanajiri
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Endoplasmic Reticulum Stress
Cell Cycle Arrest
Hodgkin Lymphoma
Nk Cells
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Kanae Imai
,
Yuki Takeuchi
,
Seitaro Terakura
,
Shingo Okuno
,
Yoshitaka Adachi
,
Masahide Osaki
,
Koji Umemura
,
Ryo Hanajiri
,
Kazuyuki Shimada
,
Makoto Murata
,
Hitoshi Kiyoi
Dual CAR-T cells targeting CD19 and CD37 are effective in target antigen loss B cell tumor models.
Molecular cancer therapeutics
(2023)